134 related articles for article (PubMed ID: 9441114)
1. Pleural mesothelioma: an approach to diagnostic problems.
Wang NS
Respirology; 1996 Dec; 1(4):259-71. PubMed ID: 9441114
[TBL] [Abstract][Full Text] [Related]
2. The cytologic diagnosis of mesothelioma.
Ehya H
Semin Diagn Pathol; 1986 Aug; 3(3):196-203. PubMed ID: 3616223
[TBL] [Abstract][Full Text] [Related]
3. Mesothelioma as a risk indicator of asbestos exposure: the role of the pathologist.
Zampi G; Comin CE; Dini S
Med Lav; 1995; 86(5):389-92. PubMed ID: 8684289
[TBL] [Abstract][Full Text] [Related]
4. A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumours.
Garcia-Prats MD; Ballestin C; Sotelo T; Lopez-Encuentra A; Mayordomo JI
Histopathology; 1998 May; 32(5):462-72. PubMed ID: 9639123
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic histochemical and immunohistochemical studies in malignant mesothelioma.
Lucas JG; Tuttle SE
J Surg Oncol; 1987 May; 35(1):30-4. PubMed ID: 2437407
[TBL] [Abstract][Full Text] [Related]
6. Mucin-positive epithelial mesotheliomas: a histochemical, immunohistochemical, and ultrastructural comparison with mucin-producing pulmonary adenocarcinomas.
Hammar SP; Bockus DE; Remington FL; Rohrbach KA
Ultrastruct Pathol; 1996; 20(4):293-325. PubMed ID: 8837337
[TBL] [Abstract][Full Text] [Related]
7. Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals.
Attanoos RL; Thomas DH; Gibbs AR
Histopathology; 2003 Oct; 43(4):387-92. PubMed ID: 14511258
[TBL] [Abstract][Full Text] [Related]
8. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma.
Ordóñez NG
Am J Surg Pathol; 1989 Apr; 13(4):276-91. PubMed ID: 2648877
[TBL] [Abstract][Full Text] [Related]
9. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.
Brown RW; Clark GM; Tandon AK; Allred DC
Hum Pathol; 1993 Apr; 24(4):347-54. PubMed ID: 7684019
[TBL] [Abstract][Full Text] [Related]
10. Screening and pathological diagnosis of asbestosis and mesothelioma: a review.
Zalay Z; Nemeth L; Sugar J
J Environ Pathol Toxicol Oncol; 1992; 11(5-6):317-21. PubMed ID: 1464814
[TBL] [Abstract][Full Text] [Related]
11. Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohistologic study of 103 cases.
Wick MR; Loy T; Mills SE; Legier JF; Manivel JC
Hum Pathol; 1990 Jul; 21(7):759-66. PubMed ID: 2193875
[TBL] [Abstract][Full Text] [Related]
12. Synovial sarcoma and malignant mesothelioma of the pleura: review, differential diagnosis and possible role of apoptosis.
Cappello F; Barnes L
Pathology; 2001 May; 33(2):142-8. PubMed ID: 11358044
[TBL] [Abstract][Full Text] [Related]
13. Complementary value of five carcinoma markers for the diagnosis of malignant mesothelioma, adenocarcinoma metastasis, and reactive mesothelium in serous effusions.
Delahaye M; van der Ham F; van der Kwast TH
Diagn Cytopathol; 1997 Aug; 17(2):115-20. PubMed ID: 9258618
[TBL] [Abstract][Full Text] [Related]
14. Asbestos and the pleura: a review.
Cugell DW; Kamp DW
Chest; 2004 Mar; 125(3):1103-17. PubMed ID: 15006974
[No Abstract] [Full Text] [Related]
15. Asbestosis and asbestos-related disease.
Dark DS; Pingleton SK
J Kans Med Soc; 1983 Jul; 84(7):392-6, 413. PubMed ID: 6886517
[No Abstract] [Full Text] [Related]
16. Benign and malignant pleural mesothelioma.
Antman KH; Corson JM
Clin Chest Med; 1985 Mar; 6(1):127-40. PubMed ID: 3891207
[TBL] [Abstract][Full Text] [Related]
17. The diagnosis of mesothelioma by panels.
McCaughey WT
Am J Ind Med; 1991; 19(1):121-4. PubMed ID: 1989432
[No Abstract] [Full Text] [Related]
18. [Pathologic study of pleural and peritoneal mesotheliomas of rats induced by asbestos].
Tan XM
Zhonghua Bing Li Xue Za Zhi; 1991 Sep; 20(3):187-9. PubMed ID: 1782687
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic tools for differentiating between pleural mesothelioma and lung adenocarcinoma in paraffin embedded tissue. Part I: Immunohistochemical findings.
Moch H; Oberholzer M; Dalquen P; Wegmann W; Gudat F
Virchows Arch A Pathol Anat Histopathol; 1993; 423(1):19-27. PubMed ID: 8212530
[TBL] [Abstract][Full Text] [Related]
20. A comparative immunohistochemical study of malignant mesothelioma and renal cell carcinoma: the diagnostic utility of Leu-M1, Ber EP4, Tamm-Horsfall protein and thrombomodulin.
Attanoos RL; Goddard H; Thomas ND; Jasani B; Gibbs AR
Histopathology; 1995 Oct; 27(4):361-6. PubMed ID: 8847067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
